• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高激素避孕方法依从性和可接受性的策略。

Strategies to improve adherence and acceptability of hormonal methods of contraception.

作者信息

Halpern Vera, Lopez Laureen M, Grimes David A, Stockton Laurie L, Gallo Maria F

机构信息

Clinical Sciences, FHI 360, PO Box 13950, Research Triangle Park, North Carolina, USA, NC 27709.

出版信息

Cochrane Database Syst Rev. 2013 Oct 26(10):CD004317. doi: 10.1002/14651858.CD004317.pub4.

DOI:10.1002/14651858.CD004317.pub4
PMID:24163097
Abstract

BACKGROUND

Worldwide, hormonal contraceptives are among the most popular reversible contraceptives. Despite their high theoretical effectiveness, typical use results in much lower effectiveness. In large part, this disparity reflects difficulties in adherence to the contraceptive regimen and low rates for long-term continuation.

OBJECTIVES

The intent was to determine the effectiveness of ancillary counseling techniques to improve adherence to, and continuation of, hormonal methods of contraception.

SEARCH METHODS

Through August 2013, we searched computerized databases for randomized controlled trials (RCTs) comparing client-provider interventions with standard family planning counseling. Sources included CENTRAL, MEDLINE, EMBASE, POPLINE, ClinicalTrials.gov and ICTRP. Earlier searches also included LILACS, PsycINFO, Dissertation Abstracts, African Index Medicus, and IMEMR.

SELECTION CRITERIA

We included RCTs of an intensive counseling technique or other client-provider intervention compared to routine family planning counseling. Interventions included group motivation; structured, peer, or multi-component counseling; and intensive reminders of appointments or next dosing. Outcome measures were discontinuation, reasons for discontinuation, number of missed pills or on-time injections, and pregnancy.

DATA COLLECTION AND ANALYSIS

One author evaluated the titles and abstracts from the searches to determine eligibility. Two authors extracted data from the included studies. We calculated the Mantel-Haenszel odds ratio (OR) for dichotomous outcomes. For continuous variables, the mean difference (MD) was computed; RevMan uses the inverse variance approach. For all analyses, 95% confidence intervals (CI) were also computed. Since the studies identified differed in both interventions and outcome measures, we did not conduct a meta-analysis.

MAIN RESULTS

Nine RCTs met our inclusion criteria. Five involved direct counseling; of those, two also provided multiple contacts by telephone. Four other trials provided intensive reminders, two of which also provided health education information. Three trials showed some benefit of the experimental intervention. In a counseling intervention, women who received repeated structured information about the injectable depot medroxyprogesterone acetate (DMPA) were less likely to discontinue the method by 12 months (OR 0.27; 95% CI 0.16 to 0.44) than women who had routine counseling. The intervention group was also less likely to discontinue due to menstrual disturbances (OR 0.20; 95% CI 0.11 to 0.37). Another trial showed a group with special counseling plus phone calls was more likely than the special-counseling group to report consistent use of oral contraceptives (OC) at 3 months (OR 1.41; 95% CI 1.06 to 1.87), though not at 12 months. The group with only special counseling did not differ significantly from those with standard care for any outcome. The third trial compared daily text-message reminders about OCs plus health information versus standard care. Women in the text-message group were more likely than the standard-care group to continue OC use by six months (OR 1.54; 95% CI 1.14 to 2.10). The text-message group was also more likely to avoid an interruption in OC use longer than seven days (OR 1.53; 95% CI 1.13 to 2.07).

AUTHORS' CONCLUSIONS: Only three trials showed some benefit of strategies to improve adherence and continuation. However, several had small sample sizes and six had high losses to follow up. The overall quality of evidence was considered moderate. The intervention type and intensity varied greatly across the studies. A combination of intensive counseling and multiple contacts and reminders may be needed to improve adherence and acceptability of contraceptive use. High-quality RCTs with adequate power and well-designed interventions could help identify ways to improve adherence to, and continuation of, hormonal contraceptive methods.

摘要

背景

在全球范围内,激素避孕药是最受欢迎的可逆性避孕方法之一。尽管其理论有效性较高,但实际使用效果却低得多。在很大程度上,这种差异反映了坚持避孕方案的困难以及长期持续使用的低比率。

目的

旨在确定辅助咨询技术对提高激素避孕方法的依从性和持续使用的有效性。

检索方法

截至2013年8月,我们在计算机化数据库中检索了比较客户 - 提供者干预与标准计划生育咨询的随机对照试验(RCT)。来源包括Cochrane系统评价数据库、医学索引数据库、荷兰医学文摘数据库、人口信息数据库、临床试验.gov和国际临床试验注册平台。早期检索还包括拉丁美洲和加勒比地区卫生科学数据库、心理学文摘数据库、论文摘要数据库、非洲医学索引和印度医学研究理事会数据库。

选择标准

我们纳入了与常规计划生育咨询相比的强化咨询技术或其他客户 - 提供者干预的随机对照试验。干预措施包括群体激励;结构化、同伴或多成分咨询;以及强化预约提醒或下次服药提醒。结局指标为停药、停药原因、漏服避孕药或按时注射次数以及妊娠情况。

数据收集与分析

一位作者评估检索结果中的标题和摘要以确定是否符合纳入标准。两位作者从纳入研究中提取数据。我们计算了二分结局的Mantel - Haenszel优势比(OR)。对于连续变量,计算平均差(MD);RevMan使用逆方差法。对于所有分析,还计算了95%置信区间(CI)。由于所确定的研究在干预措施和结局指标方面均存在差异,因此我们未进行荟萃分析。

主要结果

九项随机对照试验符合我们的纳入标准。五项涉及直接咨询;其中两项还通过电话提供多次联系。其他四项试验提供强化提醒,其中两项还提供健康教育信息。三项试验显示了实验性干预的一些益处。在一项咨询干预中,与接受常规咨询的女性相比,接受关于醋酸甲羟孕酮长效注射剂(DMPA)的重复结构化信息的女性在12个月时停用该方法的可能性较小(OR 0.27;95%CI 0.16至0.44)。干预组因月经紊乱而停药的可能性也较小(OR 0.20;95%CI 0.11至0.37)。另一项试验表明,接受特殊咨询加电话随访的组在3个月时比仅接受特殊咨询的组更有可能报告持续使用口服避孕药(OC)(OR 1.41;95%CI 1.06至1.87),但在12个月时并非如此。仅接受特殊咨询的组与接受标准护理的组在任何结局方面均无显著差异。第三项试验比较了关于口服避孕药的每日短信提醒加健康信息与标准护理。短信组的女性在6个月时比标准护理组更有可能继续使用口服避孕药(OR 1.54;95%CI 1.14至2.10)。短信组也更有可能避免口服避孕药使用中断超过7天(OR 1.53;95%CI 1.13至2.07)。

作者结论

只有三项试验显示了改善依从性和持续使用的策略的一些益处。然而,其中几项样本量较小,六项随访损失率较高。证据的总体质量被认为是中等的。各项研究中的干预类型和强度差异很大。可能需要强化咨询与多次联系及提醒相结合,以提高避孕使用的依从性和可接受性。具有足够效力和精心设计干预措施的高质量随机对照试验有助于确定改善激素避孕方法的依从性和持续使用的方法。

相似文献

1
Strategies to improve adherence and acceptability of hormonal methods of contraception.提高激素避孕方法依从性和可接受性的策略。
Cochrane Database Syst Rev. 2013 Oct 26(10):CD004317. doi: 10.1002/14651858.CD004317.pub4.
2
Strategies to improve adherence and acceptability of hormonal methods of contraception.提高激素避孕方法依从性和可接受性的策略。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD004317. doi: 10.1002/14651858.CD004317.pub3.
3
Strategies to improve adherence and acceptability of hormonal methods for contraception.提高激素避孕方法依从性和可接受性的策略。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004317. doi: 10.1002/14651858.CD004317.pub2.
4
Brief educational strategies for improving contraception use in young people.提高年轻人避孕措施使用率的简短教育策略。
Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD012025. doi: 10.1002/14651858.CD012025.pub2.
5
Behavioral interventions for improving contraceptive use among women living with HIV.改善感染艾滋病毒妇女避孕措施使用情况的行为干预措施。
Cochrane Database Syst Rev. 2013 Jan 31(1):CD010243. doi: 10.1002/14651858.CD010243.pub2.
6
Strategies for communicating contraceptive effectiveness.传达避孕效果的策略。
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD006964. doi: 10.1002/14651858.CD006964.pub3.
7
Education for contraceptive use by women after childbirth.产后妇女避孕方法的教育。
Cochrane Database Syst Rev. 2012 Aug 15(8):CD001863. doi: 10.1002/14651858.CD001863.pub3.
8
Education for contraceptive use by women after childbirth.产后妇女避孕方法教育。
Cochrane Database Syst Rev. 2015 Jul 29;2015(7):CD001863. doi: 10.1002/14651858.CD001863.pub4.
9
Progestin-only contraceptives: effects on weight.仅含孕激素的避孕药:对体重的影响。
Cochrane Database Syst Rev. 2016 Aug 28;2016(8):CD008815. doi: 10.1002/14651858.CD008815.pub4.
10
School-based interventions for improving contraceptive use in adolescents.以学校为基础的干预措施,用于提高青少年的避孕措施使用率。
Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD012249. doi: 10.1002/14651858.CD012249.

引用本文的文献

1
Patient Perceived Quality of Virtual Group Contraception Counseling.患者对虚拟群组避孕咨询的感知质量
Open Access J Contracept. 2024 Jul 4;15:99-105. doi: 10.2147/OAJC.S467537. eCollection 2024.
2
Comparison of Combined Parenteral and Oral Hormonal Contraceptives: A Systematic Review and Meta-Analysis of Randomized Trials.胃肠外与口服激素避孕药的比较:随机试验的系统评价与荟萃分析
J Clin Med. 2024 Jan 19;13(2):575. doi: 10.3390/jcm13020575.
3
If fear of infertility restricts contraception use, what do we know about this fear? An examination in rural Ethiopia.
如果对不孕的恐惧限制了避孕措施的使用,我们对这种恐惧了解多少?对埃塞俄比亚农村的考察。
Reprod Health. 2022 Jun 13;19(Suppl 1):57. doi: 10.1186/s12978-021-01267-9.
4
Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions.理论导向型问卷评估医疗干预措施可接受性的开发。
BMC Health Serv Res. 2022 Mar 1;22(1):279. doi: 10.1186/s12913-022-07577-3.
5
Modeling the impact of a health coaching intervention to prevent teen pregnancy.模拟健康指导干预对预防青少年怀孕的影响。
Prev Med Rep. 2022 Jan 29;26:101716. doi: 10.1016/j.pmedr.2022.101716. eCollection 2022 Apr.
6
Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development Study.宫内节育系统新用户的数字医疗设备伴侣(MyIUS):应用程序开发研究
JMIR Med Inform. 2021 Jul 13;9(7):e24633. doi: 10.2196/24633.
7
"… the way we welcome them is how we will lead them to love family planning.": family planning providers in Rwanda foster compassionate relationships with clients despite workplace challenges.“……我们欢迎他们的方式就是我们引导他们热爱计划生育的方式”:尽管面临工作场所的挑战,卢旺达的计划生育服务提供者仍与客户建立富有同情心的关系。
BMC Health Serv Res. 2021 Apr 1;21(1):293. doi: 10.1186/s12913-021-06282-x.
8
An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.一个互动网站,帮助年轻女性选择避孕方法:可行性和有效性 RCT。
Health Technol Assess. 2020 Nov;24(56):1-44. doi: 10.3310/hta24560.
9
Contraceptive use among sexually active women living with HIV in western Ethiopia.埃塞俄比亚西部活跃性伴 HIV 感染女性的避孕措施使用情况。
PLoS One. 2020 Aug 6;15(8):e0237212. doi: 10.1371/journal.pone.0237212. eCollection 2020.
10
Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review.左炔诺孕酮宫内节育系统作为未生育女性的避孕方法:一项系统评价。
J Clin Med. 2020 Jul 3;9(7):2101. doi: 10.3390/jcm9072101.